Poster # 2401 PSA Response To Tri-modality (HDR Brachytherapy, Hypofractionated 3D-CRT, Neoadjuvant/Adjuvant Androgen Therapy) Predicts Biochemical Progression Free Survival In Localized Prostate Cancer

Presenter: Manabu Aoki, MD




 View the poster



E-mail a friend about this poster:
Enter email address: